
Anne Wojcicki wanted to run things—alone.
It was 2009 and her startup 23andMe was riding high, fueled by a steady stream of venture money, intriguing personal accounts of genome exploration, and the novelty of “spit parties.”

Anne Wojcicki wanted to run things—alone.
It was 2009 and her startup 23andMe was riding high, fueled by a steady stream of venture money, intriguing personal accounts of genome exploration, and the novelty of “spit parties.”